Key result
Macrophage-restricted overexpression of Grx1 eliminated sex differences unmasked by high-calorie diet feeding and reduced atherosclerosis by 39% in male and 35% in female mice.
Why the study?
High-calorie diet-induced nutrient stress promotes thiol oxidative stress and monocyte reprogramming into dysregulated, obesogenic, proatherogenic macrophages.
Does Grx1 modulation affect macrophage reprogramming, obesity, and atherosclerosis in a sex-specific manner in mice?
Does Grx1 modulation affect macrophage reprogramming, obesity, and atherosclerosis in a sex-specific manner in mice?
Loss of monocytic Grx1 activity disrupts immunometabolic balance and reveals sexually dimorphic oxidative stress responses, potentially explaining sex differences in cardiovascular disease and obesity.
Grx1 may drive sex-specific atherogenesis in aging females; leaves open human relevance and therapeutic targeting.
High-calorie diet-induced nutrient stress promotes thiol oxidative stress and the reprogramming of blood monocytes, giving rise to dysregulated, obesogenic, proatherogenic monocyte-derived macrophages. We report that in chow-fed, reproductively senescent female mice but not in age-matched male mice, deficiency in the thiol transferase glutaredoxin 1 (Grx1) promotes dysregulated macrophage phenotypes as well as rapid weight gain and atherogenesis. Grx1 deficiency derepresses distinct expression patterns of reactive oxygen species and reactive nitrogen species generators in male versus female macrophages, poising female but not male macrophages for increased peroxynitrate production. Hematopoietic Grx1 deficiency recapitulates this sexual dimorphism in high-calorie diet-fed LDLR -/- mice, whereas macrophage-restricted overexpression of Grx1 eliminates the sex differences unmasked by high-calorie diet-feeding and protects both males and females against atherogenesis. We conclude that loss of monocytic Grx1 activity disrupts the immunometabolic balance in mice and derepresses sexually dimorphic oxidative stress responses in macrophages. This mechanism may contribute to the sex differences reported in cardiovascular disease and obesity in humans.
No takes yet. Share an insight, caveat, or question.
Ahn et al. (2022) studied Obesity and atherosclerosis. Grx1 deficiency and macrophage-restricted Grx1 overexpression vs. Wild-type or EGFP-overexpressing controls was evaluated on Atherosclerotic lesion size. Macrophage-restricted overexpression of Grx1 eliminated sex differences unmasked by high-calorie diet feeding and reduced atherosclerosis by 39% in male and 35% in female mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: